Cargando…

The PI3K p110δ Regulates Expression of CD38 on Regulatory T Cells

The PI3K pathway has emerged as a key regulator of regulatory T cell (Treg) development and homeostasis and is required for full Treg-mediated suppression. To identify new genes involved in PI3K-dependent suppression, we compared the transcriptome of WT and p110δ(D910A) Tregs. Among the genes that w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patton, Daniel T., Wilson, Marcus D., Rowan, Wendy C., Soond, Dalya R., Okkenhaug, Klaus
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046981/ https://www.ncbi.nlm.nih.gov/pubmed/21390257 http://dx.doi.org/10.1371/journal.pone.0017359

Ejemplares similares

Inactivation of the PI3K p110δ breaks regulatory T cell-mediated immune tolerance to cancer
por: Ali, Khaled, et al.
Publicado: (2014)

Does the PI3K pathway promote or antagonize regulatory T cell development and function?
por: Soond, Dalya R., et al.
Publicado: (2012)

Antigen receptor signalling: a distinctive role for the p110δ isoform of PI3K
por: Okkenhaug, Klaus, et al.
Publicado: (2007)

PI3K p110δ Is Expressed by gp38(−)CD31(+) and gp38(+)CD31(+) Spleen Stromal Cells and Regulates Their CCL19, CCL21, and LTβR mRNA Levels
por: Zotes, Teresa M., et al.
Publicado: (2013)

PI3Kδ promotes CD4(+) T-cell interactions with antigen-presenting cells by increasing LFA-1 binding to ICAM-1
por: Garçon, Fabien, et al.
Publicado: (2016)

Obesity-Induced Metabolic Stress Leads to Biased Effector Memory CD4(+) T Cell Differentiation via PI3K p110δ-Akt-Mediated Signals
por: Mauro, Claudio, et al.
Publicado: (2017)

Discovery of Novel PI3Kδ Inhibitors Based on the p110δ Crystal Structure
por: Jia, Wenqing, et al.
Publicado: (2022)

PI3Kδ Regulates the Magnitude of CD8(+) T Cell Responses after Challenge with Listeria monocytogenes
por: Pearce, Verity Q., et al.
Publicado: (2015)

Immunomodulation of Selective Naive T Cell Functions by p110δ Inactivation Improves the Outcome of Mismatched Cell Transplantation
por: Doisne, Jean-Marc, et al.
Publicado: (2015)

PI3Kδ Forms Distinct Multiprotein Complexes at the TCR Signalosome in Naïve and Differentiated CD4(+) T Cells
por: Luff, Daisy H., et al.
Publicado: (2021)

Regulation of p110δ PI 3-Kinase Gene Expression
por: Kok, Klaartje, et al.
Publicado: (2009)

Genetic or Pharmaceutical Blockade of Phosphoinositide 3-Kinase P110δ Prevents Chronic Rejection of Heart Allografts
por: Ying, Huijun, et al.
Publicado: (2012)

The p110δ crystal structure uncovers mechanisms for selectivity and potency of novel PI3K inhibitors
por: Berndt, Alex, et al.
Publicado: (2010)

Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury
por: Bilancio, Antonio, et al.
Publicado: (2017)

Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ
por: Hassenrück, Floyd, et al.
Publicado: (2023)

Pharmacologic inhibition of PI3K p110δ in mutant Shp2E76K-expressing mice
por: Deng, Lisa, et al.
Publicado: (2017)

p110δ PI3 kinase pathway: emerging roles in cancer
por: Tzenaki, Niki, et al.
Publicado: (2013)

Class IA PI3K regulatory subunits: p110-independent roles and structures
por: Fox, Millie, et al.
Publicado: (2020)

Disrupted PI3K p110δ Signaling Dysregulates Maternal Immune Cells and Increases Fetal Mortality In Mice
por: Kieckbusch, Jens, et al.
Publicado: (2015)

Pharmacological inactivation of the PI3K p110δ prevents breast tumour progression by targeting cancer cells and macrophages
por: Goulielmaki, Evangelia, et al.
Publicado: (2018)

Isoform-selective induction of human p110δ PI3K expression by TNFα: identification of a new and inducible PIK3CD promoter
por: Whitehead, Maria A., et al.
Publicado: (2012)

Control of Axonal Growth and Regeneration of Sensory Neurons by the p110δ PI 3-Kinase
por: Eickholt, Britta J., et al.
Publicado: (2007)

The p110δ of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation
por: Guo, Hailong, et al.
Publicado: (2008)

Phosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse
por: Hu, Xiwen, et al.
Publicado: (2016)

PI3K Signaling in B Cell and T Cell Biology
por: Okkenhaug, Klaus, et al.
Publicado: (2014)

Deficiency of PI3-Kinase catalytic isoforms p110γ and p110δ in mice enhances the IL-17/G-CSF axis and induces neutrophilia
por: Bucher, Kirsten, et al.
Publicado: (2017)

Author Correction: Phosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse
por: Hu, Xiwen, et al.
Publicado: (2020)

Inhibition of Vps34 and p110δ PI3K Impairs Migration, Invasion and Three-Dimensional Spheroid Growth in Breast Cancer Cells
por: Di Donato, Marzia, et al.
Publicado: (2022)

PI3Kinase-p110δ Overexpression Impairs Dendritic Morphogenesis and Increases Dendritic Spine Density
por: Hood, Veronica L., et al.
Publicado: (2020)

PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL)
por: Okkenhaug, Klaus, et al.
Publicado: (2015)

p38γ and p38δ Are Involved in T Lymphocyte Development
por: Risco, Ana, et al.
Publicado: (2018)

PI3K inhibitors in inflammation, autoimmunity and cancer
por: Stark, Anne-Katrien, et al.
Publicado: (2015)

Dominant Role of PI3K p110α over p110β in Insulin and β-Adrenergic Receptor Signalling
por: Zhang, Biqin, et al.
Publicado: (2021)

The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases
por: Banham-Hall, Edward, et al.
Publicado: (2012)

New Insights into the p38γ and p38δ MAPK Pathways
por: Risco, Ana, et al.
Publicado: (2012)

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
por: Zhang, Lei, et al.
Publicado: (2020)

PI3K in T Cell Adhesion and Trafficking
por: Johansen, Kristoffer H., et al.
Publicado: (2021)

Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma
por: Katsuya, Hiroo, et al.
Publicado: (2018)

SMER28 Attenuates PI3K/mTOR Signaling by Direct Inhibition of PI3K p110 Delta
por: Kirchenwitz, Marco, et al.
Publicado: (2022)

Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor
por: Berenjeno, Inma M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3c7kssajthm1cl1tsnncq0nhg8